Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 183 entries
Sorted by: Best Match Show Resources per page
Inflammatory biomarkers in asthma-COPD overlap syndrome.

International journal of chronic obstructive pulmonary disease

Kobayashi S, Hanagama M, Yamanda S, Ishida M, Yanai M.
PMID: 27660429
Int J Chron Obstruct Pulmon Dis. 2016 Sep 07;11:2117-2123. doi: 10.2147/COPD.S113647. eCollection 2016.

BACKGROUND: The clinical phenotypes and underlying mechanisms of asthma-COPD overlap syndrome (ACOS) remain elusive. This study aimed to investigate a comparison of COPD patients with and without ACOS, focusing on inflammatory biomarkers, in an outpatient COPD cohort.METHODS: We conducted...

Cite
Kobayashi S, Hanagama M, Yamanda S, et al. Inflammatory biomarkers in asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2016;11:2117-2123doi: 10.2147/COPD.S113647.
Kobayashi, S., Hanagama, M., Yamanda, S., Ishida, M., & Yanai, M. (2016). Inflammatory biomarkers in asthma-COPD overlap syndrome. International journal of chronic obstructive pulmonary disease, 112117-2123. https://doi.org/10.2147/COPD.S113647
Kobayashi, Seiichi, et al. "Inflammatory biomarkers in asthma-COPD overlap syndrome." International journal of chronic obstructive pulmonary disease vol. 11 (2016): 2117-2123. doi: https://doi.org/10.2147/COPD.S113647
Kobayashi S, Hanagama M, Yamanda S, Ishida M, Yanai M. Inflammatory biomarkers in asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2016 Sep 07;11:2117-2123. doi: 10.2147/COPD.S113647. eCollection 2016. PMID: 27660429; PMCID: PMC5021052.
Copy Download .nbib Format: NLM
Application of the homology method for quantification of low-attenuation lung region inpatients with and without COPD.

International journal of chronic obstructive pulmonary disease

Nishio M, Nakane K, Tanaka Y.
PMID: 27660430
Int J Chron Obstruct Pulmon Dis. 2016 Sep 06;11:2125-2137. doi: 10.2147/COPD.S110504. eCollection 2016.

BACKGROUND: Homology is a mathematical concept that can be used to quantify degree of contact. Recently, image processing with the homology method has been proposed. In this study, we used the homology method and computed tomography images to quantify...

Cite
Nishio M, Nakane K, Tanaka Y. Application of the homology method for quantification of low-attenuation lung region inpatients with and without COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2125-2137doi: 10.2147/COPD.S110504.
Nishio, M., Nakane, K., & Tanaka, Y. (2016). Application of the homology method for quantification of low-attenuation lung region inpatients with and without COPD. International journal of chronic obstructive pulmonary disease, 112125-2137. https://doi.org/10.2147/COPD.S110504
Nishio, Mizuho, et al. "Application of the homology method for quantification of low-attenuation lung region inpatients with and without COPD." International journal of chronic obstructive pulmonary disease vol. 11 (2016): 2125-2137. doi: https://doi.org/10.2147/COPD.S110504
Nishio M, Nakane K, Tanaka Y. Application of the homology method for quantification of low-attenuation lung region inpatients with and without COPD. Int J Chron Obstruct Pulmon Dis. 2016 Sep 06;11:2125-2137. doi: 10.2147/COPD.S110504. eCollection 2016. PMID: 27660430; PMCID: PMC5019166.
Copy Download .nbib Format: NLM
The disease burden of chronic obstructive pulmonary disease in Greece.

International journal of chronic obstructive pulmonary disease

Kourlaba G, Hillas G, Vassilakopoulos T, Maniadakis N.
PMID: 27672323
Int J Chron Obstruct Pulmon Dis. 2016 Sep 09;11:2179-2189. doi: 10.2147/COPD.S110373. eCollection 2016.

BACKGROUND: The objective of the study was to estimate the self-reported prevalence of chronic obstructive pulmonary disease (COPD) in Greece and to quantify its burden on patients' daily activities, productivity, and psychological status.METHODS: A population-based, random digit-dialed telephone nationwide...

Cite
Kourlaba G, Hillas G, Vassilakopoulos T, et al. The disease burden of chronic obstructive pulmonary disease in Greece. Int J Chron Obstruct Pulmon Dis. 2016;11:2179-2189doi: 10.2147/COPD.S110373.
Kourlaba, G., Hillas, G., Vassilakopoulos, T., & Maniadakis, N. (2016). The disease burden of chronic obstructive pulmonary disease in Greece. International journal of chronic obstructive pulmonary disease, 112179-2189. https://doi.org/10.2147/COPD.S110373
Kourlaba, Georgia, et al. "The disease burden of chronic obstructive pulmonary disease in Greece." International journal of chronic obstructive pulmonary disease vol. 11 (2016): 2179-2189. doi: https://doi.org/10.2147/COPD.S110373
Kourlaba G, Hillas G, Vassilakopoulos T, Maniadakis N. The disease burden of chronic obstructive pulmonary disease in Greece. Int J Chron Obstruct Pulmon Dis. 2016 Sep 09;11:2179-2189. doi: 10.2147/COPD.S110373. eCollection 2016. PMID: 27672323; PMCID: PMC5025008.
Copy Download .nbib Format: NLM
Depression in COPD--management and quality of life considerations.

International journal of chronic obstructive pulmonary disease

Stage KB, Middelboe T, Stage TB, Sørensen CH.
PMID: 18046868
Int J Chron Obstruct Pulmon Dis. 2006;1(3):315-20. doi: 10.2147/copd.2006.1.3.315.

Depression is common in COPD patients. Around 40% are affected by severe depressive symptoms or clinical depression. It is not easy to diagnose depression in COPD patients because of overlapping symptoms between COPD and depression. However, the six-item Hamilton...

Cite
Stage KB, Middelboe T, Stage TB, et al. Depression in COPD--management and quality of life considerations. Int J Chron Obstruct Pulmon Dis. 2006;1(3):315-20doi: 10.2147/copd.2006.1.3.315.
Stage, K. B., Middelboe, T., Stage, T. B., & Sørensen, C. H. (2006). Depression in COPD--management and quality of life considerations. International journal of chronic obstructive pulmonary disease, 1(3), 315-20. https://doi.org/10.2147/copd.2006.1.3.315
Stage, Kurt B, et al. "Depression in COPD--management and quality of life considerations." International journal of chronic obstructive pulmonary disease vol. 1,3 (2006): 315-20. doi: https://doi.org/10.2147/copd.2006.1.3.315
Stage KB, Middelboe T, Stage TB, Sørensen CH. Depression in COPD--management and quality of life considerations. Int J Chron Obstruct Pulmon Dis. 2006;1(3):315-20. doi: 10.2147/copd.2006.1.3.315. PMID: 18046868; PMCID: PMC2707161.
Copy Download .nbib Format: NLM
Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease.

International journal of chronic obstructive pulmonary disease

Jones PW, Price D, van der Molen T.
PMID: 21697993
Int J Chron Obstruct Pulmon Dis. 2011;6:289-96. doi: 10.2147/COPD.S18181. Epub 2011 May 26.

Chronic obstructive pulmonary disease (COPD) is a leading cause of disability in all its stages, and death in patients with moderate or severe obstruction. At present, COPD is suboptimally managed; current health is often not measured properly and hardly...

Cite
Jones PW, Price D, van der Molen T. Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011;6:289-96doi: 10.2147/COPD.S18181.
Jones, P. W., Price, D., & van der Molen, T. (2011). Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease. International journal of chronic obstructive pulmonary disease, 6289-96. https://doi.org/10.2147/COPD.S18181
Jones, Paul W, et al. "Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease." International journal of chronic obstructive pulmonary disease vol. 6 (2011): 289-96. doi: https://doi.org/10.2147/COPD.S18181
Jones PW, Price D, van der Molen T. Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011;6:289-96. doi: 10.2147/COPD.S18181. Epub 2011 May 26. PMID: 21697993; PMCID: PMC3119104.
Copy Download .nbib Format: NLM
GOLD and the fixed ratio.

International journal of chronic obstructive pulmonary disease

Vestbo J.
PMID: 23049251
Int J Chron Obstruct Pulmon Dis. 2012;7:663; author reply 664. doi: 10.2147/COPD.S35769. Epub 2012 Sep 25.

No abstract available.

Cite
Vestbo J. GOLD and the fixed ratio. Int J Chron Obstruct Pulmon Dis. 2012;7:663; author reply 664doi: 10.2147/COPD.S35769.
Vestbo, J. (2012). GOLD and the fixed ratio. International journal of chronic obstructive pulmonary disease, 7663; author reply 664. https://doi.org/10.2147/COPD.S35769
Vestbo, Jørgen. "GOLD and the fixed ratio." International journal of chronic obstructive pulmonary disease vol. 7 (2012): 663; author reply 664. doi: https://doi.org/10.2147/COPD.S35769
Vestbo J. GOLD and the fixed ratio. Int J Chron Obstruct Pulmon Dis. 2012;7:663; author reply 664. doi: 10.2147/COPD.S35769. Epub 2012 Sep 25. PMID: 23049251; PMCID: PMC3459655.
Copy Download .nbib Format: NLM
Respiratory health and quality of life in young exclusive, habitual smokers - a comparison of waterpipe smokers, cigarette smokers and non-smokers.

International journal of chronic obstructive pulmonary disease

Hawari FI, Obeidat NA, Abu Alhalawa M, Al-Busaidi Z, Amara B, Baddar S, Elhabiby M, Elkholy H.
PMID: 31496680
Int J Chron Obstruct Pulmon Dis. 2019 Aug 13;14:1813-1824. doi: 10.2147/COPD.S205050. eCollection 2019.

PURPOSE: Waterpipe (WP) use has become a global trend in young populations. However, there are few well-controlled studies focusing specifically on the chronic effects of exclusive WP use on young adults' respiratory health. We sought to compare in young...

Cite
Hawari FI, Obeidat NA, Abu Alhalawa M, et al. Respiratory health and quality of life in young exclusive, habitual smokers - a comparison of waterpipe smokers, cigarette smokers and non-smokers. Int J Chron Obstruct Pulmon Dis. 2019;14:1813-1824doi: 10.2147/COPD.S205050.
Hawari, F. I., Obeidat, N. A., Abu Alhalawa, M., Al-Busaidi, Z., Amara, B., Baddar, S., Elhabiby, M., & Elkholy, H. (2019). Respiratory health and quality of life in young exclusive, habitual smokers - a comparison of waterpipe smokers, cigarette smokers and non-smokers. International journal of chronic obstructive pulmonary disease, 141813-1824. https://doi.org/10.2147/COPD.S205050
Hawari, F I, et al. "Respiratory health and quality of life in young exclusive, habitual smokers - a comparison of waterpipe smokers, cigarette smokers and non-smokers." International journal of chronic obstructive pulmonary disease vol. 14 (2019): 1813-1824. doi: https://doi.org/10.2147/COPD.S205050
Hawari FI, Obeidat NA, Abu Alhalawa M, Al-Busaidi Z, Amara B, Baddar S, Elhabiby M, Elkholy H. Respiratory health and quality of life in young exclusive, habitual smokers - a comparison of waterpipe smokers, cigarette smokers and non-smokers. Int J Chron Obstruct Pulmon Dis. 2019 Aug 13;14:1813-1824. doi: 10.2147/COPD.S205050. eCollection 2019. PMID: 31496680; PMCID: PMC6698154.
Copy Download .nbib Format: NLM
Erratum: Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum].

International journal of chronic obstructive pulmonary disease

[No authors listed]
PMID: 32099349
Int J Chron Obstruct Pulmon Dis. 2020 Feb 03;15:247-248. doi: 10.2147/COPD.S246084. eCollection 2020.

[This corrects the article DOI: 10.2147/COPD.S231808.].

Cite
Erratum: Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum]. Int J Chron Obstruct Pulmon Dis. 2020;15:247-248doi: 10.2147/COPD.S246084.
(2020). Erratum: Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum]. International journal of chronic obstructive pulmonary disease, 15247-248. https://doi.org/10.2147/COPD.S246084
"Erratum: Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum]." International journal of chronic obstructive pulmonary disease vol. 15 (2020): 247-248. doi: https://doi.org/10.2147/COPD.S246084
Erratum: Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum]. Int J Chron Obstruct Pulmon Dis. 2020 Feb 03;15:247-248. doi: 10.2147/COPD.S246084. eCollection 2020. PMID: 32099349; PMCID: PMC7007496.
Copy Download .nbib Format: NLM
Erratum: Patient Selection for Bronchoscopic Lung Volume Reduction [Corrigendum].

International journal of chronic obstructive pulmonary disease

[No authors listed]
PMID: 32581525
Int J Chron Obstruct Pulmon Dis. 2020 May 27;15:1179-1180. doi: 10.2147/COPD.S262810. eCollection 2020.

[This corrects the article DOI: 10.2147/COPD.S240848.].

Cite
Erratum: Patient Selection for Bronchoscopic Lung Volume Reduction [Corrigendum]. Int J Chron Obstruct Pulmon Dis. 2020;15:1179-1180doi: 10.2147/COPD.S262810.
(2020). Erratum: Patient Selection for Bronchoscopic Lung Volume Reduction [Corrigendum]. International journal of chronic obstructive pulmonary disease, 151179-1180. https://doi.org/10.2147/COPD.S262810
"Erratum: Patient Selection for Bronchoscopic Lung Volume Reduction [Corrigendum]." International journal of chronic obstructive pulmonary disease vol. 15 (2020): 1179-1180. doi: https://doi.org/10.2147/COPD.S262810
Erratum: Patient Selection for Bronchoscopic Lung Volume Reduction [Corrigendum]. Int J Chron Obstruct Pulmon Dis. 2020 May 27;15:1179-1180. doi: 10.2147/COPD.S262810. eCollection 2020. PMID: 32581525; PMCID: PMC7267785.
Copy Download .nbib Format: NLM
Erratum: Effect of tiotropium/olodaterol on sedentary and active time in patients with COPD: post hoc analysis of the VESUTO.

International journal of chronic obstructive pulmonary disease

[No authors listed]
PMID: 31564853
Int J Chron Obstruct Pulmon Dis. 2019 Sep 03;14:2061-2064. doi: 10.2147/COPD.S229124. eCollection 2019.

[This corrects the article DOI: 10.2147/COPD.S208081.].

Cite
Erratum: Effect of tiotropium/olodaterol on sedentary and active time in patients with COPD: post hoc analysis of the VESUTO. Int J Chron Obstruct Pulmon Dis. 2019;14:2061-2064doi: 10.2147/COPD.S229124.
(2019). Erratum: Effect of tiotropium/olodaterol on sedentary and active time in patients with COPD: post hoc analysis of the VESUTO. International journal of chronic obstructive pulmonary disease, 142061-2064. https://doi.org/10.2147/COPD.S229124
"Erratum: Effect of tiotropium/olodaterol on sedentary and active time in patients with COPD: post hoc analysis of the VESUTO." International journal of chronic obstructive pulmonary disease vol. 14 (2019): 2061-2064. doi: https://doi.org/10.2147/COPD.S229124
Erratum: Effect of tiotropium/olodaterol on sedentary and active time in patients with COPD: post hoc analysis of the VESUTO. Int J Chron Obstruct Pulmon Dis. 2019 Sep 03;14:2061-2064. doi: 10.2147/COPD.S229124. eCollection 2019. PMID: 31564853; PMCID: PMC6733181.
Copy Download .nbib Format: NLM
Erratum: Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East-North Africa region, 2017 [Corrigendum].

International journal of chronic obstructive pulmonary disease

[No authors listed]
PMID: 30718947
Int J Chron Obstruct Pulmon Dis. 2019 Jan 18;14:115. doi: 10.2147/COPD.S194431. eCollection 2019.

[This corrects the article on p. 2869 in vol. 12, PMID: 29070946.].

Cite
Erratum: Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East-North Africa region, 2017 [Corrigendum]. Int J Chron Obstruct Pulmon Dis. 2019;14:115doi: 10.2147/COPD.S194431.
(2019). Erratum: Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East-North Africa region, 2017 [Corrigendum]. International journal of chronic obstructive pulmonary disease, 14115. https://doi.org/10.2147/COPD.S194431
"Erratum: Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East-North Africa region, 2017 [Corrigendum]." International journal of chronic obstructive pulmonary disease vol. 14 (2019): 115. doi: https://doi.org/10.2147/COPD.S194431
Erratum: Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East-North Africa region, 2017 [Corrigendum]. Int J Chron Obstruct Pulmon Dis. 2019 Jan 18;14:115. doi: 10.2147/COPD.S194431. eCollection 2019. PMID: 30718947; PMCID: PMC6343746.
Copy Download .nbib Format: NLM
Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group.

International journal of chronic obstructive pulmonary disease

Greulich T, Albert A, Cassel W, Boeselt T, Peychev E, Klemmer A, Ferreira F, Clarenbach C, Torres-Duran ML, Turner AM, Miravitlles M.
PMID: 35023913
Int J Chron Obstruct Pulmon Dis. 2022 Jan 05;17:53-64. doi: 10.2147/COPD.S346051. eCollection 2022.

BACKGROUND: Augmentation therapy (AT) is the only specific treatment licensed for patients with alpha-1 antitrypsin deficiency (AATD) associated lung disease. Since patients with severe AATD may have a very different prognosis and AT requires intravenous infusions for life, the...

Cite
Greulich T, Albert A, Cassel W, et al. Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group. Int J Chron Obstruct Pulmon Dis. 2022;17:53-64doi: 10.2147/COPD.S346051.
Greulich, T., Albert, A., Cassel, W., Boeselt, T., Peychev, E., Klemmer, A., Ferreira, F., Clarenbach, C., Torres-Duran, M. L., Turner, A. M., & Miravitlles, M. (2022). Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group. International journal of chronic obstructive pulmonary disease, 1753-64. https://doi.org/10.2147/COPD.S346051
Greulich, Timm, et al. "Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group." International journal of chronic obstructive pulmonary disease vol. 17 (2022): 53-64. doi: https://doi.org/10.2147/COPD.S346051
Greulich T, Albert A, Cassel W, Boeselt T, Peychev E, Klemmer A, Ferreira F, Clarenbach C, Torres-Duran ML, Turner AM, Miravitlles M. Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group. Int J Chron Obstruct Pulmon Dis. 2022 Jan 05;17:53-64. doi: 10.2147/COPD.S346051. eCollection 2022. PMID: 35023913; PMCID: PMC8743984.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 183 entries